Great Lakes Research Group, Inc   Report issue

For profit Phase 3
Founded: Bay City MI United States (2004)

Organization Overview

First Clinical Trial
2010
NCT01188928
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

betamethasone (celestone) (1 trial)

calcipotriene (dovonex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Psoriasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2